scholarly article | Q13442814 |
P50 | author | Alain Verstraete | Q43112072 |
Detlev Boison | Q43161293 | ||
Wytse Wadman | Q55232157 | ||
Paul Boon | Q87110922 | ||
Kristl Vonck | Q87110930 | ||
Robrecht Raedt | Q87110933 | ||
Annelies Van Dycke | Q123200027 | ||
P2093 | author name string | Panos Theofilas | |
P2860 | cites work | Early identification of refractory epilepsy | Q28144133 |
Stem cells for the treatment of neurological disorders | Q28249501 | ||
Grafts of adenosine-releasing cells suppress seizures in kindling epilepsy | Q28366761 | ||
Overexpression of adenosine kinase in epileptic hippocampus contributes to epileptogenesis | Q28585948 | ||
Critical issues of clinical human embryonic stem cell therapy for brain repair | Q33318601 | ||
Quantitative analysis of adenosine using liquid chromatography/atmospheric pressure chemical ionization-tandem mass spectrometry (LC/APCI-MS/MS) | Q33446142 | ||
Adenosine and suppression of seizures | Q33748604 | ||
Neonatal hepatic steatosis by disruption of the adenosine kinase gene | Q34068093 | ||
Adenosine kinase, epilepsy and stroke: mechanisms and therapies | Q34575897 | ||
Uncoupling of astrogliosis from epileptogenesis in adenosine kinase (ADK) transgenic mice | Q34606639 | ||
Potential new methods for antiepileptic drug delivery | Q34769911 | ||
Stem cell therapy for human neurodegenerative disorders-how to make it work | Q35844778 | ||
The epidemiology of epilepsy in Europe - a systematic review. | Q36085957 | ||
Actions of adenosine at its receptors in the CNS: insights from knockouts and drugs | Q36094581 | ||
The adenosine kinase hypothesis of epileptogenesis | Q36515651 | ||
New routes for delivery of anti-epileptic medications. | Q36703655 | ||
Concise review: prospects of stem cell therapy for temporal lobe epilepsy. | Q36729233 | ||
Genetically engineered human neural stem cells for brain repair in neurological diseases | Q36736590 | ||
Silk polymer-based adenosine release: therapeutic potential for epilepsy | Q36819103 | ||
Cell therapy in models for temporal lobe epilepsy | Q36848783 | ||
Adenosine dysfunction in astrogliosis: cause for seizure generation? | Q36923994 | ||
Adenosine and its receptors: multiple modulatory functions and potential therapeutic targets for neurologic disease | Q37057037 | ||
Cell and gene therapies for refractory epilepsy. | Q37211817 | ||
Adenosine augmentation therapies (AATs) for epilepsy: prospect of cell and gene therapies. | Q37269991 | ||
Antiepileptic effects of silk-polymer based adenosine release in kindled rats. | Q37310106 | ||
Suppression of kindled seizures by paracrine adenosine release from stem cell-derived brain implants | Q40390719 | ||
Seizure suppression in kindled rats by intraventricular grafting of an adenosine releasing synthetic polymer | Q40782752 | ||
Adenosine kinase is a target for the prediction and prevention of epileptogenesis in mice | Q41862804 | ||
Continuous local intrahippocampal delivery of adenosine reduces seizure frequency in rats with spontaneous seizures | Q42931136 | ||
Unconditioned adult-derived neurosphere cells mainly differentiate towards astrocytes upon transplantation in sclerotic rat hippocampus | Q43275753 | ||
Stimulus- and cell-type-specific release of purines in cultured rat forebrain astrocytes and neurons | Q44792372 | ||
Engineering embryonic stem cell derived glia for adenosine delivery | Q45109679 | ||
Seizure suppression and lack of adenosine A1 receptor desensitization after focal long-term delivery of adenosine by encapsulated myoblasts | Q45882674 | ||
Suppression of kindling epileptogenesis by adenosine releasing stem cell-derived brain implants. | Q48181919 | ||
Shift of adenosine kinase expression from neurons to astrocytes during postnatal development suggests dual functionality of the enzyme. | Q48465634 | ||
Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935-1984. | Q51052283 | ||
Focal treatment for refractory epilepsy: hope for the future? | Q79739749 | ||
P433 | issue | 7 | |
P921 | main subject | astrocyte | Q502961 |
P304 | page(s) | 390-396 | |
P577 | publication date | 2010-06-17 | |
P1433 | published in | Seizure-European Journal of Epilepsy | Q15753758 |
P1476 | title | Astrocytes derived from fetal neural progenitor cells as a novel source for therapeutic adenosine delivery | |
P478 | volume | 19 |
Search more.